Key facts
- Techpool’s last known valuation is $432.8M (May 2018).
- It has raised $14.7M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Guangzhou Science and Technology Financial Innovation Investment Holding, Shanghai Pharmaceuticals, Starr International Company, Takeda Pharmaceutical.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Techpool
- ·The full record, as it builds
Funding rounds
No funding rounds for Techpool are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Techpool
Manufacturer of biopharmaceutical products intended for hospitals, healthcare providers, and pharmaceutical distributors. The company focuses on research, development, production, and marketing of biopharmaceuticals, thereby enabling customers to achieve improved patient outcomes, access to cutting-edge therapies, and compliance with international standards.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 1993
- Employees
- 840
- Website
- techpool.com.cn/
- Ownership
- Privately Held (backing)
Techpool doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Techpool shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Techpool in its N-PORT filings yet. We sweep new filings monthly.